Healthcare Unfiltered Express
Healthcare Unfiltered Express curates quick-hit conversations between Dr. Chadi Nabhan and his guests on hot-button topics in the healthcare world today.
Episodes
64 episodes
Episode 64: Updates on Lung Cancer from 2026-WCLC
The World Congress on Lung Cancer in Seoul has just concluded, and the insightful Dr. Chul Kim of Georgetown University and Medstar Health joined #HealthcareUnfiltered EXPRESS to share his valuable opinions on practice changing/informing data p...
Episode 63: AI and Radiology
Pranav Rajpurkar, co-founder of A2Z Radiology, joins Healthcare Unfiltered EXPRESS to discuss the current—and future—state of AI in radiology. How will AI transform the field? What will it mean for radiologists, physicians, and patients? And wh...
Episode 62: Does Alcohol Cause Cancer?
Dr. Gilberto Lopes, senior author on a recent Lancet publication addressing alcohol and cancer, joins the show to share the findings of hs group research, and the broader implications of alcohol and various cancers. Is there a safe level for al...
Episode 61: AI Tumor Twins with Bishoy Faltas
Dr. Bishoy Flatas, a pioneer in bladder cancer research at Cornell, joins the show to highlight his work on AI Tumor Twins and his in-silico model for predicting which drugs may be more effective for certain bladder cancers, optimizing clinical...
Episode 60: The SUCCESSOR-2 Trial in Myeloma
I am joined by the amazing Dr. Paul Richardson from the Dana-Farber Cancer Institute to discuss the SUCCESSOR trial that was presented at EHA. This trial discusses CELMoDs by highlighting a landmark randomized Phase 3 clinical study evaluating ...
Episode 59: ASCO 2026 Lung Cancer Updates
Dr. Bruna Pellini of Baptist Health Miami Cancer Institute joins Healthcare Unfiltered EXPRESS to break down the most important lung cancer data presented at ASCO 2026. Together, we discuss the trials most likely to influence clinical practice,...
Episode 58: The ENDURANCE (E1A11) Myeloma Trial in NEJM
Hot off the press, the ENDURANCE trial was JUST published in NEJM. This trial explored whether patients with newly diagnosed myeloma benefit from long-term maintenance lenalidomide versus 2-years only. Dr. Vincent Rajkumar, senior auth...
Episode 57: The KOMET-007 Trial
Dr. Amer Zeidan joins the Healthcare Unfiltered EXPRESS to discuss the recently published KOMET-007 trial, which made its way to print in Blood. Dr. Zeidan discusses how Menin inhibitors are transforming how we approach AML like no oth...
Episode 56: AI and Patient Care
On this Healthcare Unfiltered EXPRESS, Dr. Arturo Bonilla, CMO of Massive Bio and an AI oncologist expert who leads many AI efforts nationally, joined Chadi to provide his insights on where AI is being applied in patient care. He gives timely u...
Episode 55: New Approvals for Breast Cancer
Dr. Virginia Kaklamani joins Healthcare Unfiltered EXPRESS to discuss the recent FDA-approved indications for T-DXd in breast cancer, and what this means for treating patients with the disease. A critical episode ahead of the annual ASCO meetin...
Episode 54: Updates from ESMO Breast 2026 in Berlin
Dr. Rani Bansal of Duke University joins the show to share her insights on the latest ESMO Breast meeting that concluded in Berlin. Dr. Rani shares data on the top 5 abstracts that may change or inform practice.Check it out, share, subsc...
Episode 53: Hantavirus: The Facts
Dr. Emily Landon of the University of Chicago joins the show to explain everything you must know about the Hantavirus - should we be concerned? What to do? What not to do? Is this another COVID?Get the facts right here, and please share, su...
Episode 52: A New Trial in Pancreatic Cancer
Dr. Deva Mahalingam shares on Healthcare Unfiltered EXPRESS a new paper published in Nature Medicine on a regimen showing significant promise in pancreatic cancer. You want to listen to this podcast and check out the paper.
Episode 51: Treating Relapsed/Refractory CLL
Dr. Matt Davids of the Dana Farber Cancer Institute joins Healthcare Unfiltered EXPRESS to share his data-solidified insights on navigating the treatment of relapsed/refractory (R/R) CLL, considering the welcome advances the field has witnessed...
Episode 50: The MajesTEC-3 Trial in Myeloma
Dr. Vincent Rajkumar of the Mayo Clinic joins the Healthcare Unfiltered EXPRESS to highlight a major study recently published in the NEJM concerning patients with R/R multiple myeloma. This study is arguably changing the standard of ca...
Episode 49: Bladder Cancer Updates From ASCO GU 2026
Dr. Andrea Apolo from the NCI and the co-Chair of the ASCO GU 2026 scientific program joined the Healthcare Unfiltered EXPRESS to share what she viewed as potentially practice-changing data in bladder cancer. She discussed what she viewed as th...
Episode 48: Renal and Prostate Cancer ASCO GU Updates
Dr. Shilpa Gupta of Cleveland Clinic joins Healthcare Unfiltered EXPRESS to share three major abstracts from the ASCO-GU-2026 meeting that could change clinical practice in kidney and prostate cancers. Dr. Gupta brings this data home by explain...
Episode 47: The Approval of Zongertinib
Dr. Eric Singhi of the MD Anderson Cancer Center joins Healthcare Unfiltered EXPRESS to describe this newly approved drug, its target, the trial that led to its approval, and how it fits into the treatment armamentarium for lung cancer. Please ...
Episode 46: Menin Inhibitors in AML
Arguably, the development and approval of Menin Inhibitors in AML are one of the most important advances in this disease in the past 1-2 years. Dr. Uma Borate joins Healthcare Unfiltered EXPRESS and shares with us everything we must know about ...
Episode 45: The BRUIN-313 Trial in CLL
Dr. Marc Braunstein from NYU Langone joins the Healthcare Unfiltered EXPRESS to describe the recently published BRUIN-313 trial in frontline CLL and its potential impact on the treatment landscape for this disease. Check it out, subscribe, shar...
Episode 44: Burnout and AI
Dr. Ishwaria Subbiah joined the Healthcare Unfiltered EXPRESS to discuss burnout, a problem physicians and many other healthcare providers face. She offers that AI and technology may bring solutions to reduce this problem and improve satisfacti...
Episode 43: The ASCENT-04 Trial in TNBC With Sara Tolaney
Dr. Sara Tolaney of the Dana-Farber Cancer Institute joined the show to share her insights on the ASCENT-04 trial recently published in NEJM. This is an RCT in triple-negative breast cancer. Sara led this study and as the lead author, ...
Episode 42: CELMoDs in Myeloma
Dr. Ajay Nooka of Emory University and the Winship Cancer Institute joins Healthcare Unfiltered EXPRESS to tell us about CELMoDs in multiple myeloma. What are these agents? How do they work? How do they help patients with myeloma? And what does...
Episode 41: An ASCO GI 2026 Chat With Pashtoon Kasi
Dr. Kasi from the City of Hope joins the Healthcare Unfiltered EXPRESS for a chat on what intrigued him at the last ASCO GI meeting that took place a few weeks ago. What mattered and did any standards of care changed?Take a listen, share...